170 related articles for article (PubMed ID: 10618619)
1. Tumor markers at the time of recurrence in patients with germ cell tumors.
Trigo JM; Tabernero JM; Paz-Ares L; García-Llano JL; Mora J; Lianes P; Esteban E; Salazar R; López-López JJ; Cortés-Funes H
Cancer; 2000 Jan; 88(1):162-8. PubMed ID: 10618619
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiographic characterization of primary seminomas and nonseminomatous germ cell tumors.
Gu L; Zhang L; Hou N; Li M; Shen W; Xie X; Teng Y
Niger J Clin Pract; 2019 Mar; 22(3):342-349. PubMed ID: 30837421
[TBL] [Abstract][Full Text] [Related]
3. The present and future of serum diagnostic tests for testicular germ cell tumours.
Murray MJ; Huddart RA; Coleman N
Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
[TBL] [Abstract][Full Text] [Related]
4. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
[TBL] [Abstract][Full Text] [Related]
5. Utility of serum tumor markers during surveillance for stage I seminoma.
Vesprini D; Chung P; Tolan S; Gospodarowicz M; Jewett M; O'Malley M; Sweet J; Moore M; Panzarella T; Sturgeon J; Sugar L; Anson-Cartwright L; Warde P
Cancer; 2012 Nov; 118(21):5245-50. PubMed ID: 22517478
[TBL] [Abstract][Full Text] [Related]
6. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
J Clin Oncol; 1997 Feb; 15(2):594-603. PubMed ID: 9053482
[TBL] [Abstract][Full Text] [Related]
7. Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
Murphy BA; Motzer RJ; Mazumdar M; Vlamis V; Nisselbaum J; Bajorin D; Bosl GJ
Cancer; 1994 May; 73(10):2520-6. PubMed ID: 7513603
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.
von Eyben FE
Clin Biochem; 2001 Sep; 34(6):441-54. PubMed ID: 11676973
[TBL] [Abstract][Full Text] [Related]
9. AFP and HCG in germ cell tumors.
Bassetto MA; Franceschi T; Lenotti M; Parise G; Pancheri F; Sabbioni R; Zaninelli M; Cetto GL
Int J Biol Markers; 1994; 9(1):29-32. PubMed ID: 7519651
[TBL] [Abstract][Full Text] [Related]
10. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
[TBL] [Abstract][Full Text] [Related]
11. Laboratory markers and germ cell tumors.
von Eyben FE
Crit Rev Clin Lab Sci; 2003 Aug; 40(4):377-427. PubMed ID: 14582602
[TBL] [Abstract][Full Text] [Related]
12. Importance of a new tumor marker TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors.
Gels ME; Marrink J; Visser P; Sleijfer DT; Droste JH; Hoekstra HJ; Andrews PW; Schraffordt Koops H
Ann Surg Oncol; 1997 Jun; 4(4):321-7. PubMed ID: 9181232
[TBL] [Abstract][Full Text] [Related]
13. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Morris MJ; Bosl GJ
J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
[TBL] [Abstract][Full Text] [Related]
15. Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.
Otto T; Virchow S; Fuhrmann C; Steinberg F; Streffer C; Goepel M; Rübben H
Urol Res; 1997; 25(2):121-4. PubMed ID: 9144879
[TBL] [Abstract][Full Text] [Related]
16. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors.
Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of tumor markers in the treatment of germ cell tumors].
Germá Lluch JR; García del Muro X; Galán MC
Arch Esp Urol; 2000; 53(6):460-8. PubMed ID: 11002513
[TBL] [Abstract][Full Text] [Related]
19. [The role of tumor markers in the treatment of germ cell tumor].
Niwakawa M; Tobisu K
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1159-65. PubMed ID: 11525037
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer.
Lajer H; Daugaard G; Andersson AM; Skakkebaek NE
Int J Cancer; 2002 Jul; 100(2):244-6. PubMed ID: 12115576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
